These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 35440318)

  • 1. Liposomal Drug Delivery and Its Potential Impact on Cancer Research.
    Bhattacharya S; Saindane D; Prajapati BG
    Anticancer Agents Med Chem; 2022 Aug; 22(15):2671-2683. PubMed ID: 35440318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updates on the use of liposomes for active tumor targeting in cancer therapy.
    Yan W; Leung SS; To KK
    Nanomedicine (Lond); 2020 Feb; 15(3):303-318. PubMed ID: 31802702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in liposome-based targeted cancer therapy.
    Fidan Y; Muçaj S; Timur SS; Gürsoy RN
    J Liposome Res; 2024 Jun; 34(2):316-334. PubMed ID: 37814217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel tumor-targeted thermosensitive liposomal cerasome used for thermally controlled drug release.
    Li S; Yin G; Pu X; Huang Z; Liao X; Chen X
    Int J Pharm; 2019 Oct; 570():118660. PubMed ID: 31491484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal drug delivery systems: an update review.
    Samad A; Sultana Y; Aqil M
    Curr Drug Deliv; 2007 Oct; 4(4):297-305. PubMed ID: 17979650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced liposome and polymersome-based drug delivery systems: Considerations for physicochemical properties, targeting strategies and stimuli-sensitive approaches.
    Kansız S; Elçin YM
    Adv Colloid Interface Sci; 2023 Jul; 317():102930. PubMed ID: 37290380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted liposomal drug delivery: a nanoscience and biophysical perspective.
    Liu Y; Castro Bravo KM; Liu J
    Nanoscale Horiz; 2021 Feb; 6(2):78-94. PubMed ID: 33400747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Progress in Bioconjugation Strategies for Liposome-Mediated Drug Delivery.
    Almeida B; Nag OK; Rogers KE; Delehanty JB
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33271886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomes for Tumor Targeted Therapy: A Review.
    Wang S; Chen Y; Guo J; Huang Q
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomes in the Targeted Gene Therapy of Cancer: A Critical Review.
    Akkewar A; Mahajan N; Kharwade R; Gangane P
    Curr Drug Deliv; 2023; 20(4):350-370. PubMed ID: 35593362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal Delivery Systems: Design Optimization and Current Applications.
    Abu Lila AS; Ishida T
    Biol Pharm Bull; 2017; 40(1):1-10. PubMed ID: 28049940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-penetrating corosolic acid liposome as a functional carrier for delivering chemotherapeutic drugs.
    Li X; Widjaya AS; Liu J; Liu X; Long Z; Jiang Y
    Acta Biomater; 2020 Apr; 106():301-313. PubMed ID: 32081779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted liposomal drug delivery in cancer.
    Medina OP; Zhu Y; Kairemo K
    Curr Pharm Des; 2004; 10(24):2981-9. PubMed ID: 15379663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in development of targeted liposomal therapeutics.
    Sawant RR; Torchilin VP
    AAPS J; 2012 Jun; 14(2):303-15. PubMed ID: 22415612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albumin-Encapsulated Liposomes: A Novel Drug Delivery Carrier With Hydrophobic Drugs Encapsulated in the Inner Aqueous Core.
    Okamoto Y; Taguchi K; Yamasaki K; Sakuragi M; Kuroda S; Otagiri M
    J Pharm Sci; 2018 Jan; 107(1):436-445. PubMed ID: 28826882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advancements of Stimuli-Responsive Targeted Liposomal Formulations for Cancer Drug Delivery.
    Alrbyawi H; Poudel I; Annaji M; Arnold RD; Tiwari AK; Babu RJ
    Pharm Nanotechnol; 2022; 10(1):3-23. PubMed ID: 35156590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligation strategies for targeting liposomal nanocarriers.
    Marqués-Gallego P; de Kroon AI
    Biomed Res Int; 2014; 2014():129458. PubMed ID: 25126543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape.
    Zylberberg C; Matosevic S
    Drug Deliv; 2016 Nov; 23(9):3319-3329. PubMed ID: 27145899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A liposomal drug platform overrides peptide ligand targeting to a cancer biomarker, irrespective of ligand affinity or density.
    Gray BP; McGuire MJ; Brown KC
    PLoS One; 2013; 8(8):e72938. PubMed ID: 24009717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposome-based diagnostic and therapeutic applications for pancreatic cancer.
    Raza F; Evans L; Motallebi M; Zafar H; Pereira-Silva M; Saleem K; Peixoto D; Rahdar A; Sharifi E; Veiga F; Hoskins C; Paiva-Santos AC
    Acta Biomater; 2023 Feb; 157():1-23. PubMed ID: 36521673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.